Search | IOVS | ARVO Journals

View

Showing 1 – 12 of 12

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

The impact of treatment intensity over 3 years of real-world data of neovascular age-related macular degeneration

Olga Gkorou; Holly Joan Duncan; Jeffry Hogg; Lydia Grace Stone; Michelle Blyth; Lesley Brandes; Adele Devenport; Leanne Timms; James Stephen Talks

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):449. doi:

ARVO Annual Meeting Abstract June 2021

Real-world outcomes for pro re nata and treat and extend regimens in exudative age-related macular degeneration

Holly Joan Duncan; Lydia Stone; Jeffry Hogg; Olga Gkorou; Michelle Blyth; Lesley Brandes; Adele Devenport; Leanne Timms; James Stephen Talks

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):639. doi:

ARVO Annual Meeting Abstract June 2021

An observational clinical study of the influence of phacoemulsification on choroidal neovascular membrane activity in age related macular degeneration

Jordan Reed; Nicholas Chung; George Benjamin Berrett; Mark Pearce; Jeffry Hogg; Sandro Di Simplicio

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):635. doi:

ARVO Annual Meeting Abstract June 2021

The Heidelberg Flex™ imaging system as a non-invasive bedside test of intracranial pressure

Grace George; Jeffry Hogg; Kenneth Hodson; Jonathan Shelton; Chris Cowie; Satnam Dlay; Melissa Gough; Will Innes

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1878. doi:

ARVO Annual Meeting Abstract June 2021

Random Forest model matches clinician performance in forecasting visual outcomes from anti-VEGF treatment in retinal vein occlusion.

Sumeia Ahmed A. Elkazza; Grace George; North East Trainee Research in Ophthalmology Network; Sandro Di Simplicio; Jeffry Hogg; Satnam Dlay

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3192. doi:

ARVO Annual Meeting Abstract June 2021

The prevalence and impact of treatment delays in exudative age-related macular degeneration

Jeffry Hogg; Olga Gkorou; Holly Joan Duncan; Lydia Grace Stone; Michelle Blyth; Lesley Brandes; Adele Devenport; Leanne Timms; James Stephen Talks

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2941. doi:

ARVO Annual Meeting Abstract July 2019

The temporal relationship of anti-VEGF injections and the development of neovascularisation in central retinal vein occlusion

Jeffry Hogg; Sandro Di Simplicio; James S Talks

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2594. doi:

ARVO Annual Meeting Abstract July 2018

A longitudinal study of the relationship between signs and symptoms in keratoconjunctivitis sicca

Jeffry Hogg; Dahlia Ismail; Jean-Sebastien Garrigue; Maëva Deniaud; Mourad Amrane; Francisco C Figueiredo

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):934. doi:

ARVO Annual Meeting Abstract September 2016

Understanding ocular surface inflammation in tears before and after ex vivo expanded autologous limbal stem cell transplantation (ALSCT)

Gustavo S Figueiredo; Jeffry Hogg; Arthur Okonkwo; Deborah Stocken; Simi Ali; Majlinda Lako; Francisco C Figueiredo

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):893. doi:

ARVO Annual Meeting Abstract September 2016

Severe acute ocular chemical injuries – retrospective clinical audit of 38 consecutive new admissions in a tertiary hospital in the UK

Borja Salvador-Culla; Jeffry Hogg; Arthur Okonkwo; Julie Mulroy; Gustavo S Figueiredo; Francisco C Figueiredo

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3056. doi:

ARVO Annual Meeting Abstract June 2015

Stenotrophomonas maltophilia Keratitis - A Case Series of a Rare Form of Keratitis

Jeffry Hogg; Arthur Okonkwo; Manjusha Narayanan; We Fong Siah; Francisco C Figueiredo

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):5645. doi:

ARVO Annual Meeting Abstract June 2015

Microbial Keratitis Outcome in Corneal Grafts

Arthur Okonkwo; Jeffry Hogg; Hamed Anwar; We Fong Siah; Francisco C Figueiredo

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4871. doi:

Advertisement